🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the effica...
Status
Recruiting
Location
University of Alabama at Birmingham- Site Number : 8400003
Start Date
2025-09-17
Trial ID
NCT07190222
Treatments Being Tested
This is a single-arm extension study to investigate the long-term safety, t...
Status
Enrolling By Invitation
Location
Modena Allergy + Asthma- Site Number : 8400005
Start Date
2025-05-12
Trial ID
NCT06914908
Treatments Being Tested
This is a parallel-group, Phase 2, randomized, double-blind, placebo-contro...
Status
Active Not Recruiting
Location
The Center for Clinical Trials - Saraland- Site Number : 8400096
Start Date
2024-11-07
Trial ID
NCT06676319
This is a phase 2, open-label extension study to evaluate the long-term saf...
Status
Enrolling By Invitation
Location
Chandler Clinical Research Trials- Site Number : 8400075
Start Date
2024-09-30
Trial ID
NCT06609239
Treatments Being Tested
This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the effica...
Status
Recruiting
Location
Chandler Clinical Research Trials- Site Number : 8400025
Start Date
2025-09-16
Trial ID
NCT07190209
Treatments Being Tested
This is an open-label, Phase 3, long-term safety extension study including ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-14
Trial ID
NCT07793409
Treatments Being Tested
This is a parallel, Phase 2b, randomized, double-blind, placebo-controlled,...
Status
Completed
Location
T. Joseph Raoof MD Inc-Site Number: 8400004
Start Date
2025-01-30
Trial ID
NCT06790121
Treatments Being Tested
This is a Phase 2b, global, multicenter, randomized, double-blind, placebo-...
Status
Completed
Location
Allergy, Asthma & Immunology Associates- Site Number : 8400009
Start Date
2023-10-16
Trial ID
NCT06102005
Treatments Being Tested
This is a parallel, Phase 2, 2-arm, multicenter, randomized, double-blind, ...
Status
Completed
Location
Allergy & Rheumatology- Site Number : 8400005
Start Date
2024-07-17
Trial ID
NCT06454240
Treatments Being Tested